ACTICOAT^◊

Don’t risk infection 

Whether you’re a surgeon who’s just been presented with a new case, a nurse treating a chronic wound or working in acute care, it’s your responsibility to stay in control of infection management. 

By taking control of the approach to infection management in your teams and in the products you use, you can ensure you are in control of any threats to patient well-being and reduce patient treatment times related to infection.

ACTICOAT is a range of dressings that utilize the antimicrobial properties of silver to provide an efficient and effective barrier to bacterial penetration.³ Flexible, absorbent and conformable, each ACTICOAT variant is developed with properties specific to its required use.^1,2

With ACTICOAT, the prevention and treatment of infection starts rapidly and continues to work.

^*ACTICOAT Flex 3 and 7, ACTICOAT and ACTICOAT 7
^**ACTICOAT and ACTICOAT 7

References

1. Daubney, L; ACTICOAT Flex 7 - Evaluation of Extensibility, report reference DS.08.123.R1.
2. Smith & Nephew Data on File Report – 0403002.
3. Burrell et al., Efficacy of Silver-Coated Dressings as Bacterial Barriers in a Rodent Burn Sepsis Model. Wounds 1999; 11(4):64-71.
6. Westaim (Sherritt) report ref 93/001. Broad spectrum efficacy.
8. Wright et al., The Comparative Efficacy of Two Antimicrobial Barrier Dressings: In-Vitro Examination of Two Controlled Release of Silver Dressings. Wounds 1998; 10(6): 179-188.
9. Wright et al., Wound management in an era of increasing bacterial antibiotic resistance: A role for topical silver treatment. American Journal of Infection Control 1998; 26(6): 572-577.
10. Wright JB,et al., Efficacy of topical silver against fungal burn wound pathogens. Am J Infect Control 1999;27:344-350.
11. Yin HQ, Langford R, Burrell RE. Comparative evaluation of the antimicrobial activity of ACTICOAT antimicrobial barrier dressing. J Burn Care Rehabil. 1999;20:195-200.
12. Tredget et al., A Matched-Pair, Randomized Study Evaluating the Efficacy and Safety of ACTICOAT Silver-Coated Dressing for the Treatment of Burn Wounds. Journal of Burn Care and Rehabilitation 1998; 19(6): 531-537.
26. Searle and Bielby. Dressing strategies for the management of infected wounds in community wound care: impacts and implications. Poster at Wounds UK, Harrogate Nov 2010.

In burn cases where taking control of the risk of infection is critical to patient survival, you need reliable protection against the unknown.

ACTICOAT’s unique patented silver technology helps you mitigate the risk of infection over partial and full thickness wounds.

Kills 150+ pathogens 

• Broad spectrum
  » gram-positive bacteria
  » gram-negative bacteria
  » fungal wound pathogens.

When the source of bacterial contamination is unknown, a broad spectrum dressing proven effective (in vitro) against 150+ wound pathogens^6,9-11 offers your patients the reliable protection.

Fast-acting 

ACTICOAT's proprietary silver technology means it starts working within 30 minutes, reducing the opportunity for bacteria to develop antimicrobial resistance.^8-11

Easy to apply

ACTICOAT Flex adapts to the contours of the body. This makes it easier for you and your team to dress wounds, no matter how large or how severe, wherever they are on the body⁴⁰.

References

6. Westaim (Sherritt) report ref 93/001. Broad spectrum efficacy.
8. Wright et al., The Comparative Efficacy of Two Antimicrobial Barrier Dressings: In-Vitro Examination of Two Controlled Release of Silver Dressings. Wounds 1998; 10(6): 179-188.
9. Wright et al., Wound management in an era of increasing bacterial antibiotic resistance: A role for topical silver treatment. American Journal of Infection Control 1998; 26(6): 572-577.
10. Wright JB,et al., Efficacy of topical silver against fungal burn wound pathogens. Am J Infect Control 1999;27:344-350.
11. Yin HQ, Langford R, Burrell RE. Comparative evaluation of the antimicrobial activity of ACTICOAT antimicrobial barrier dressing. J Burn Care Rehabil. 1999;20:195-200.
40. Demonstrable. 

In emergency cases and acute care where taking control of the risk of infection is critical to patient survival, you need reliable protection against the unknown.

ACTICOAT’s unique patented silver technology helps you mitigate the risk of infection over partial and full thickness wounds.

Kills 150+ pathogens 

• Broad spectrum
  » gram-positive bacteria
  » gram-negative bacteria
  » fungal wound pathogens.

When the source of bacterial contamination is unknown, a broad spectrum dressing proven effective (in vitro) against 150+ wound pathogens_6,9-11 offers your patients the reliable protection.

Fast-acting 

ACTICOAT's proprietary silver technology means it starts working within 30 minutes, reducing the opportunity for bacteria to develop antimicrobial resistance.^8-11

Easy to apply

ACTICOAT Flex adapts to the contours of the body. This makes it easier for you and your team to dress wounds, no matter how large or how severe, wherever they are on the body⁴⁰.

References

6. Westaim (Sherritt) report ref 93/001. Broad spectrum efficacy.
8. Wright et al., The Comparative Efficacy of Two Antimicrobial Barrier Dressings: In-Vitro Examination of Two Controlled Release of Silver Dressings. Wounds 1998; 10(6): 179-188.
9. Wright et al., Wound management in an era of increasing bacterial antibiotic resistance: A role for topical silver treatment. American Journal of Infection Control 1998; 26(6): 572-577.
10. Wright JB,et al., Efficacy of topical silver against fungal burn wound pathogens. Am J Infect Control 1999;27:344-350.
11. Yin HQ, Langford R, Burrell RE. Comparative evaluation of the antimicrobial activity of ACTICOAT antimicrobial barrier dressing. J Burn Care Rehabil. 1999;20:195-200.
40. Demonstrable. 

Whether they are diabetic ulcers, venous ulcers or pressure ulcers, chronic infections can be difficult to treat. Left unresolved, they can lead to prolonged patient suffering and increased healthcare costs. Taking control of infection is critical to patient outcome. 

In as little as 2 weeks ACTICOAT has been shown to reduce the signs and symptoms of infection and requires fewer dressing changes than other dressings, allowing you to treat more patients more effectively.^{25, 26}

Fast-acting 

Gets to work rapidly, in as little as two weeks. ACTICOAT's proprietary silver technology is formulated to act rapidly, and can reduce the signs and symptoms of infection in as little as two weeks in infected chronic wounds.²⁵

Sustained action

ACTICOAT continues to work effectively for up to 3 or 7 days^5,35,36 depending on wear time resulting in:
» Fewer dressing changes;
» Fewer visits with a clinician;
» Less overall nurse time.

Kills 150+ pathogens  

• 150+ pathogens⁶
• Broad spectrum⁶
  » gram-positive bacteria 
  » gram-negative bacteria 
  » fungal wound pathogens. 

ACTICOAT’s proprietary silver technology means that it is effective against a very broad spectrum of pathogens so you are equipped to reduce the signs and symptoms of infection in chronic wounds with complete confidence²⁵.

References

5. Westaim 971030
6. Westaim (Sherritt) report ref 93/001. Broad spectrum efficacy.
9. Wright et al., Wound management in an era of increasing bacterial antibiotic resistance: A role for topical silver treatment. American Journal of Infection Control 1998; 26(6): 572-577.
10. Wright JB,et al., Efficacy of topical silver against fungal burn wound pathogens. Am J Infect Control 1999;27:344-350.
11. Yin HQ, Langford R, Burrell RE. Comparative evaluation of the antimicrobial activity of ACTICOAT antimicrobial barrier dressing. J Burn Care Rehabil. 1999;20:195-200.
25. Gago M, et al., A comparison of three silver-containing dressings in the treatment of infected, chronic wounds. Wounds 2008; 20 (10): 273-278.
26. Searle and Bielby. Dressing strategies for the management of infected wounds in community wound care: impacts and implications. Poster at Wounds UK, Harrogate Nov 2010.
35. Westaim Report Ref #001213 Long Term Comparative Evaluation of Silverlon and ACTICOAT 7 Dressings against MRSA.
36. Westaim Report Ref. #010322 Seven Day Efficacy of ACTICOAT 7 Dressings against multiple organisms. 

Your choice of post-operative dressing may significantly impact your re-admission rates and related healthcare costs.

Without a fast-acting, effective antimicrobial barrier dressing after surgery, patients could be left at serious risk of surgical site infections (SSIs).

ACTICOAT Surgical protects your patients against the most common bacteria in each of these surgical situations and many more. Be proactive against infection risk in your surgical procedures with ACTICOAT.

Effective barrier to bacterial penetration 

Once applied, ACTICOAT Surgical is a near-complete barrier to the penetration or spread of infection, protecting your surgical incision from infection risk.³²

Sustained action 

ACTICOAT Surgical continues to work effectively up to seven days³³, leaving you safe in the knowledge that your incision is protected once a patient has left hospital:

»Fewer dressing changes
» Fewer HCP visits
» Less overall nurse time

Easy-to-use 

ACTICOAT Surgical adhesive foam post-operative dressing has a fenestrated pad for added conformability⁴³.

»Easy to apply
»Causes minimal trauma to the site when removed, saving time and helping to ensure the patient complies with your post-operative care.

Compatible with NPWT 

ACTICOAT Flex 3 and Flex 7 can be used in combination with NPWT for up to 3 days⁴².

References

27. Whitehouse JD et al., The impact of surgical-site infections following orthopedic surgery at a community hospital and a university hospital: adverse quality of life, excess length of stay, and extra cost. Infect Control Hosp Epidemiol. 2002; 23(4):183-9.
28. Edwards JE et al., National Healthcare Safety Network (NHSN) report: Data summary for 2006 through 2008, issued December 2009. Am J Infect Control. 2009;37:783-805.
30. Harris MS, MSM, BS, MT/CLS(ASCP), CIC MHS Infection Prevention; Evelyn Hickson, RN, MSN, CNS, WCC Perinatal Clinical Nurse Specialist, Using a multi-faceted active change process and infection prevention to reduce post-op C-section infections.
32. Vaughan, Bacterial barrier testing (wet/wet) on samples of ACTICOAT Post-op, Smith & Nephew Research Centre work Report, Project number TW092, Activity number 130, Work report reference number: WRP-TW092-130-01, 2007.
33. Gaw (200&) Ref: 0708058 An in-vitro Assessment of the Bacterial Log Reduction Properties Induced by Silver Containing ACTICOAT Post-op Dressings.
42. Smith & Nephew Data on File 0810010.
43. Demonstrable.